Carriage of serogroup W-135, ET-37 meningococci in The Gambia: Implications for immunisation policy?

Citation
Jm. Maclennan et al., Carriage of serogroup W-135, ET-37 meningococci in The Gambia: Implications for immunisation policy?, LANCET, 356(9235), 2000, pp. 1078-1078
Citations number
5
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
LANCET
ISSN journal
01406736 → ACNP
Volume
356
Issue
9235
Year of publication
2000
Pages
1078 - 1078
Database
ISI
SICI code
0140-6736(20000923)356:9235<1078:COSWEM>2.0.ZU;2-A
Abstract
We found high levels of symptomless carriage of hyperinvasive Neisseria men ingitidis strain (electrophoretic type 37 [ET-37], serogroup W-135) during a vaccine trial in Gambian children in 1996. Serogroup C, ET-37 complex men ingococci cause 30-40% of meningococcal disease in countries such as the UK , and have a point prevalence of 0.5-1.0%. The recent Hai-associated spread of serogroup W-135, FT-37 complex meningococci, which has been accompanied by numerous secondary cases, might be explained by the apparently raised c arriage rates reported here.